Psychiatry and Neurology, Neurology · Raleigh, NC
NPI
1619395092
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1540 Sunday Dr
Raleigh, NC, 27607
Phone (919) 782-3456
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
51,361 services
Medicare patients, 2024
427
Average age 71
Drug cost, 2024
$5.0M
4,241 prescriptions
Company payments, 2025
$13K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Casey F Jeffreys was code J2323 (injection, natalizumab, 1 mg), 9,000 times for 22 patients. In total Casey F Jeffreys billed 51,361 services in 64 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2323 Injection, natalizumab, 1 mg | Office | 9,000 | 22 | $17.70 | $159K |
| J2350 Injection, ocrelizumab, 1 mg | Office | 7,800 | 11 | $29.03 | $226K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 3,690 | 22 | $38.65 | $143K |
| A9585 Injection, gadobutrol, 0.1 ml | Office | 3,360 | 41 | $0.25 | $841 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,148 | 19 | $0.22 | $254 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 278 | 195 | $11.41 | $3,171 |
| 99214 Office E&M - Established | Office | 251 | 181 | $81.93 | $21K |
| 96365 Intravenous Infusion, Hydration | Office | 116 | 73 | $43.54 | $5,050 |
| 96366 Intravenous Infusion, Hydration | Office | 79 | 28 | $14.59 | $1,153 |
| 96375 Injection Administration | Office | 71 | 26 | $11.11 | $789 |
| 99203 Office E&M - New | Office | 59 | 59 | $63.63 | $3,754 |
| 99204 Office E&M - New | Office | 53 | 53 | $110.01 | $5,831 |
| 99215 Office E&M - Established | Office | 49 | 41 | $89.53 | $4,387 |
| 96413 Chemotherapy Administration | Office | 43 | 30 | $90.42 | $3,888 |
| 70553 MRI/MRA - Head and Neck | Office | 42 | 42 | $114.31 | $4,801 |
By year: 2022 $296K for 16,993 services; 2023 $721K for 31,065 services; 2024 $1.3M for 51,361 services.
Medicare prescription drug claims, 2024
In 2024, the drug Casey F Jeffreys prescribed most often to Medicare patients was Gabapentin, with 323 prescriptions and refills. In total Casey F Jeffreys wrote 4,241 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 323 | 658 | 102 | $7,015 |
| Baclofen Generic | 308 | 672 | 92 | $8,291 |
| Donepezil Hcl Generic | 148 | 334 | 52 | $2,391 |
| Duloxetine Hcl Generic | 130 | 258 | 32 | $1,845 |
| Memantine Hcl Generic | 114 | 219 | 33 | $3,638 |
| Levetiracetam Generic | 113 | 243 | 31 | $3,462 |
| Tizanidine Hcl Generic | 106 | 186 | 23 | $1,763 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 96 | 190 | 24 | $1,801 |
| Kesimpta Pen Ofatumumab | 89 | 89 | Under 11 | $845K |
| Topiramate Generic | 89 | 187 | 22 | $963 |
| Dalfampridine Er Dalfampridine | 88 | 120 | 14 | $51K |
| Pregabalin Generic | 76 | 145 | 26 | $2,179 |
| Oxcarbazepine Generic | 69 | 135 | 18 | $1,783 |
| Avonex (4 Pack) Interferon Beta-1a | 66 | 66 | Under 11 | $590K |
| Sumatriptan Succinate Generic | 63 | 90 | 18 | $717 |
Brand drugs: - claims; generic drugs: 3,606 claims; opioid claims: 125.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Casey F Jeffreys $13K ($13K in general payments such as food, travel and fees) from 30 companies. The largest payer was EMD Serono, Inc. with $7,307.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 7 | $7,307 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $2,275 |
| TG Therapeutics, Inc. TGTX | 23 | $764 |
| Alexion Pharmaceuticals, Inc. AZN | 14 | $384 |
| Abbvie Inc. ABBV | 17 | $297 |
| Celgene Corporation BMY | 33 | $256 |
| Biogen, Inc. BIIB | 12 | $192 |
| Boston Scientific Corporation BSX | 3 | $180 |
| Argenx US, Inc. ARGX | 7 | $173 |
| UCB, Inc. UCB.BR | 5 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.